Navigation Links
Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
Date:10/16/2007

Agreement with Kaketsuken targets rare blood disorders

DEERFIELD, Ill., Oct. 16 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: BAX) today announced it has signed an agreement with Kaketsuken, the Chemo-Sero-Therapeutic Research Institute, based in Kumamoto Japan, for the worldwide rights to develop, manufacture and market the recombinant protein ADAMTS13. The development of recombinant ADAMTS13, a bio-engineered version of a naturally occurring enzyme that plays a critical role in blood coagulation, will strengthen Baxter's pre-clinical research and development pipeline for specialty therapeutics targeting rare diseases. In the absence of ADAMTS13 in the blood, patients develop a severe, often life-threatening condition called thrombotic thrombocytopenic purpura (TTP), marked by the formation of platelet-rich blood clots in blood vessels throughout the body. Recombinant ADAMTS13 is being developed for the treatment of TTP and related disorders and will be evaluated for other indications in the future. This agreement provides an opportunity for Baxter to exclusively develop a new recombinant protein and investigate its potential use in treating unmet medical needs.

"We are very excited to add recombinant ADAMTS13 to our development pipeline," said Hartmut J. Ehrlich, M.D., vice president of Global Research and Development for Baxter's BioScience business. "Elucidating the role of recombinant ADAMTS13 in TTP and other blood-clotting disorders might provide us with a new treatment modality for thrombotic diseases, which is a substantial addition to our R&D pipeline."

When a blood vessel is injured, a platelet plug is formed that adheres to the injury site and reduces or stops the blee
'/>"/>

SOURCE Baxter International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Expression and Purification of Recombinant Proteins That Have Native Amino Acid Sequence
2. Proteinase K, Recombinant, PCR Grade: the Ideal Tool for Template Preparations
3. Recombinant HIV Reverse Transcriptase
4. Purification of Recombinant Flavonone 3beta-Hydroxylase Using Bio-Scale CHT5-1 Hydroxyapatite Column
5. Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C
6. Cell lines expressing recombinant aequorin and a G-protein coupled receptor for functional screening
7. Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38)
8. A New C-Terminal GST Vector for Protein Production in S. pombe
9. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
10. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
11. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ROOK, N.Y., Nov. 6 BioSp...pharmaceutical company developing first-in-class c...ancial results for the third quarter ended Septemb... in September of this year, the FDA,s Arthritis Ad...e of 12-0, the approval of XIAFLEX(TM) for the tre...
(Date:11/6/2009)...MATEO, Calif., Nov. 6 ,...ed transfer of Qutenza(TM) E.U. Marketing Authoriz...icant progress in commercial readiness activities ...ior Director, Marketing; and Director, Commercial ... as director and Audit Committee chairman , ...
(Date:11/6/2009)... The agenda for Arrowhead’s 2... which is set to take place on February 22-24, 201...ee day conference we will highlight key issues in ...to share their experiences. , ...he agenda for Arrowhead’s 2010 Personalized...
(Date:11/5/2009)...IPPANY, N.J., Nov. 5 DSM Pharmaceu...manufacturing alliance with Galenix, Saint Jean D,...mercial scale manufacturing partner for Galenix co... Galenix will collaborate on business development ...echnologies, based on the strength of Galenix in d...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
... May 12 WaferGen Biosystems,Inc. (OTC Bulletin Bo...t,gene expression, genotyping, cell biology and st...Alnoor Shivji, President and Chief Executive,Offic...odman & Renshaw,Fifth Annual Global Healthcare Con...08, at the Le Meridien Beach Plaza Hotel in Monte ...
...f., May 9 Bionovo, Inc.,(Nasdaq: BNVI ) today an...uarter Results, The company did not report any re...evenues for the three months ended March 31, 2007 ...logy transfer agreement with United,Biotechnology ...inated the,agreement following notice of material ...
... May 9 Alexion,Pharmaceuticals, Inc. (Nasdaq: AL...esentation at the Bank of America 2008 Health Care...p.m., local time (7:00 p.m., eastern),on Tuesday, ...nd Chief,Financial Officer, is scheduled to presen...be available live. You can,access the webcast at: ...
Other Biology Technology:WaferGen to Present at the Rodman and Renshaw Fifth Annual Global Healthcare Conference 2Bionovo Reports First Quarter 2008 Financial Results 2Bionovo Reports First Quarter 2008 Financial Results 3Bionovo Reports First Quarter 2008 Financial Results 4Bionovo Reports First Quarter 2008 Financial Results 5Bionovo Reports First Quarter 2008 Financial Results 6
(Date:11/8/2009)...s at Purdue University have discovered a new appro...ord injuries using nano-spheres that could be inje... The synthetic "copolymer micelles" are drug-deliv...ughly 100 times smaller than the diameter of a red...w to deliver drugs for cancer treatment and other ...
(Date:11/6/2009)... harmony with their arboreal hosts. But new resear...ir trees of choice, the ants can get destructive t...n the November issue of the American Naturalist ,... trees, and it reopens a centuries-old debate on t...and certain species of plants and trees have cozy ...
(Date:11/5/2009)...ed a training grant in the amount of $2,756,719 by...tive Graduation Education and Research Training (I... awarded to Kent State. The grant, which is funded...of 2009, runs through 2014. , The grant funds an... resource sensing (EARS). The purpose of the progr...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2For Every Blow to the Head Quick Action Is Urged 48823 1For Every Blow to the Head Quick Action Is Urged 48823 2For Every Blow to the Head Quick Action Is Urged 48823 3Cosmetic Surgery Pioneer Goes Under the Knife 48821 1Cosmetic Surgery Pioneer Goes Under the Knife 48821 2Cosmetic Surgery Pioneer Goes Under the Knife 48821 3Desert Oasis Recovery an Albuquerque New Mexico Based Drug and Alcohol Addiction Treatment Center Announces a New Prescription Drug Addiction Treatm 48818 1Desert Oasis Recovery an Albuquerque New Mexico Based Drug and Alcohol Addiction Treatment Center Announces a New Prescription Drug Addiction Treatm 48818 2Desert Oasis Recovery an Albuquerque New Mexico Based Drug and Alcohol Addiction Treatment Center Announces a New Prescription Drug Addiction Treatm 48818 3Desert Oasis Recovery an Albuquerque New Mexico Based Drug and Alcohol Addiction Treatment Center Announces a New Prescription Drug Addiction Treatm 48818 4
...scription medications work successfully to cure an...f the same drug can cause an adverse reaction or n... led by Sean Cutler, an assistant professor of pla... drug responses can be analyzed by studying much s...ind variable drug responses is not peculiar to hum...
...titute of Technology has been selected by the New ...07 Excellence in Technology Education Award, in re...defining the role of the modern technological univ... annual black tie ceremony at the Liberty Science ...This is a further recognition that Stevens is an i...
...A research team led by San Jose State University a... discovered forests of a species of kelp previousl...r the Galapagos Islands. The discovery has importa...e of tropical marine systems to climate change. Th...shed in this weeks on-line issue of the Proceeding...
Other Biology News:Plants can be used to study how and why people respond differently to drugs 2Stevens wins Excellence in Technology Education Award 2Researchers discover forests of endangered tropical kelp 2
...300 (YELLOW), 1 EA. Ultrospec 6300 pro UV/Visibl...ements of the Pharmacopoeia in terms of instrument...benefits of being able to be used for rapid, discr...ent scanning capability., *Press to read high perf...
Cy3 Ab Labeling Kit from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-NPM1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
QuantiChrom Zinc Assay Kit from BioAssay Systems
Biology Products: